Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease Life Science Investing
BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics Biotech Investing
PTC Expands Relationship with Garrett Motion to Transform New Product Development Life Science Investing
Arcellx to Host Investor Relations Event During the 67th ASH Annual Meeting and Exposition Life Science Investing
Biogen and Stoke Therapeutics Announce Publication of Two-Year Natural History Data Demonstrating the Severity of Dravet Syndrome, Including Frequent Seizures and Significant Cognitive and Behavioral Impairments Life Science Investing
Stoke Therapeutics and Biogen Announce Publication of Two-Year Natural History Data Demonstrating the Severity of Dravet Syndrome, Including Frequent Seizures and Significant Cognitive and Behavioral Impairments Life Science Investing
Guardant Health Announces Launch of Single Namespace Group Uniting Leading Technology, Healthcare and Research Institutions to Set Global Standard for Exabyte-Scale Data Access Life Science Investing
Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response Monitoring Life Science Investing
